SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Lexeo Therapeutics, Inc.
@LXEO_InsiderForm 4 Filing: Townsend Richard Nolan Sells $116,242.56 of $LXEO
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Lexeo Therapeutics, Inc.
Ticker: $LXEO
Transaction Value
$116,242.56
Price/Share: $1.25
transaction date
2026-07-01
Shares: 92,947
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Townsend Richard Nolan, holds the title of Chief Executive Officer at Lexeo Therapeutics, Inc..
On 2026-07-01, the insider transacted 92,947 shares.The shares were transacted at a weighted average price of $1.25 per share, resulting in a total market-relevant value of $116,242.56.
Executive Summary Summary
Townsend Richard Nolan (Chief Executive Officer) sold $116K of $LXEO
Post-Transaction Position: 377,817 shares
SEC Accession No: 0001995218-26-000013 (CIK: 1995218)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.